By Colin Kellaher
Xtant Medical Holdings Inc. on Wednesday said it has acquired the Coflex and Cofix product lines from fellow medical-technology company Surgalign Holdings Inc. for $17 million.
Xtant, based in Belgrade, Mont., said it expects the products to add about $14 million in annual revenue and help the company achieve profitability in the near future.
The Coflex device is an implant for the treatment of lumbar spinal stenosis, while Cofix is a supplemental fixation device.
Xtant posted revenue of $42.7 million and a loss of $6.3 million for the first nine months of 2022.
Surgalign, based in Deerfield, Ill., said the transaction provides non-dilutive capital that it will use to advance its platform of artificial-intelligence products.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
March 01, 2023 09:44 ET (14:44 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.